2017 annual financial data
Avalo Therapeutics 2017 Financial results
Direct answer
Revenue was 27,813,137 USD.
Operating income was 13,889,982 USD and net income was 11,869,823 USD.
Operating cash flow was 12,519,405 USD.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 27,813,137 USD
- Operating income
- 13,889,982 USD
- Net income
- 11,869,823 USD
- Operating cash flow
- 12,519,405 USD
Explore related company data
View all 2017 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Avalo Therapeutics financial years